Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Leukemia

Free Subscription Articles published in J Natl Cancer Inst Retrieve available abstracts of 19 articles: HTML format

Single Articles

February 2025
1. PECHLIVANOGLOU P, Luu L, Li Q, Rios JD, et al
   Development of a policy model for pediatric acute lymphoblastic leukemia to facilitate economic evaluation.
   J Natl Cancer Inst. 2025 Feb 14:djaf024. doi: 10.1093.
   PubMed     Abstract available
   
   
   October 2024
2. WEN T, Sun G, Jiang W, Steiner K, et al
   Comparing the Efficacy and Safety of First-Line Treatments for Chronic Lymphocytic Leukemia: A Network Meta-Analysis.
   J Natl Cancer Inst. 2024 Oct 11:djae245. doi: 10.1093.
   PubMed     Abstract available
   
   
   August 2024
3. BROWN JC, Ma C, Shi Q, Couture F, et al
   Inflammation, Physical Activity, and Disease-Free Survival in Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance).
   J Natl Cancer Inst. 2024 Aug 24:djae203. doi: 10.1093.
   PubMed     Abstract available
   
   
   July 2024
4. 
   Editor's Note to: Targeting Primitive Chronic Myeloid Leukemia Cells by Effective Inhibition of a New AHI-1-BCR-ABL-JAK2 Complex.
   J Natl Cancer Inst. 2024 Jul 11:djae168. doi: 10.1093.
   PubMed    
   
   
   
5. SCHAFER ES, Rushing T, Crews KR, Annesley C, et al
   Optimizing early phase clinical trial washout periods: a report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium.
   J Natl Cancer Inst. 2024 Jul 4:djae165. doi: 10.1093.
   PubMed     Abstract available
   
   
   March 2024
6. HANTEL A, Brunner AM, Plascak JJ, Uno H, et al
   Race/ethnic associations with comprehensive cancer center access and clinical trial enrollment for acute leukemia.
   J Natl Cancer Inst. 2024 Mar 22:djae067. doi: 10.1093.
   PubMed     Abstract available
   
   
   January 2024
7. MAILLARD M, Nishii R, Yang W, Hoshitsuki K, et al
   Additive effects of TPMT and NUDT15 on thiopurine toxicity in children with acute lymphoblastic leukemia across multiethnic populations.
   J Natl Cancer Inst. 2024 Jan 16:djae004. doi: 10.1093.
   PubMed     Abstract available
   
   
   December 2023
8. JONES RR, Madrigal JM, Troisi R, Surcel HM, et al
   Maternal serum concentrations of per- and polyfluoroalkyl substances and childhood acute lymphoblastic leukemia.
   J Natl Cancer Inst. 2023 Dec 13:djad261. doi: 10.1093.
   PubMed     Abstract available
   
   
   November 2023
9. SIEGEL DA, King JB, Lupo PJ, Durbin EB, et al
   Counts, incidence rates, and trends of pediatric cancer in the United States, 2003-2019.
   J Natl Cancer Inst. 2023;115:1337-1354.
   PubMed     Abstract available
   
   
   June 2023
10. UMARETIYA PJ, Koch VB, Flamand Y, Aziz-Bose R, et al
    Disparities in parental distress in a multicenter clinical trial for pediatric acute lymphoblastic leukemia.
    J Natl Cancer Inst. 2023 Jun 1:djad099. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2022
11. KEATING NL, Brooks GA, Landrum MB, Liu PH, et al
    The Oncology Care Model and Adherence to Oral Cancer Drugs: A Difference-in-Differences Analysis.
    J Natl Cancer Inst. 2022;114:871-877.
    PubMed     Abstract available
    
    
    May 2022
12. ZHAO X, Qian M, Goodings C, Zhang Y, et al
    Molecular mechanisms of ARID5B-mediated genetic susceptibility to acute lymphoblastic leukemia.
    J Natl Cancer Inst. 2022 May 16. pii: 6586299. doi: 10.1093.
    PubMed     Abstract available
    
    
    
13. RODWIN RL, Kairalla JA, Hibbitts E, Devidas M, et al
    Persistence of chemotherapy-induced peripheral neuropathy despite vincristine reduction in childhood b-acute lymphoblastic leukemia.
    J Natl Cancer Inst. 2022 May 12. pii: 6584828. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2022
14. GARCIA-PRIETO CA, Villanueva L, Bueno-Costa A, Davalos V, et al
    Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell Malignancies.
    J Natl Cancer Inst. 2022;114:436-445.
    PubMed     Abstract available
    
    
    October 2021
15. LIPSYC-SHARF M, Zhang S, Ou FS, Ma C, et al
    Survival in Young-Onset Metastatic Colorectal Cancer: Findings from Cancer and Leukemia Group B (Alliance)/SWOG 80405.
    J Natl Cancer Inst. 2021 Oct 12. pii: 6390822. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2021
16. EFFICACE F, Baccarani M
    Quality of Life Improvements in Patients with Chronic Myeloid Leukemia after Stopping Long-Term Therapy: Who Can Benefit the Most?
    J Natl Cancer Inst. 2021 Sep 7. pii: 6365945. doi: 10.1093.
    PubMed    
    
    
    
17. SCHOENBECK KL, Atallah E, Lin L, Weinfurt KP, et al
    Patient-Reported Functional Outcomes in Patients with Chronic Myeloid Leukemia after Stopping Tyrosine Kinase Inhibitors.
    J Natl Cancer Inst. 2021 Sep 7. pii: 6365943. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2021
18. VAN DER PLAS E, Qiu W, Nieman BJ, Yasui Y, et al
    Sex-Specific Associations Between Chemotherapy, Chronic Conditions, and Neurocognitive Impairment in Acute Lymphoblastic Leukemia Survivors: A Report From the Childhood Cancer Survivor Study.
    J Natl Cancer Inst. 2021;113:588-596.
    PubMed     Abstract available
    
    
    October 2020
19. DUSETZINA SB, Huskamp HA, Jazowski SA, Winn AN, et al
    Oral Oncology Parity Laws, Medication Use, and Out-of-Pocket Spending for Patients With Blood Cancers.
    J Natl Cancer Inst. 2020;112:1055-1062.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.